IMP: Resolution of General Meeting of Shareholders

Resolution of General Meeting of Shareholders of Imexpharm Corporation as follows:

HOSE

>   AAA: Annual Report 2023 (09/08/2024)

>   SMN: Reviewed Semi-annual Financial Statements 2024 (09/08/2024)

>   S55: Change in Business Registration Certificate (09/08/2024)

>   V12: Board Decision on terminating Southern branch's operations (09/08/2024)

>   RCC: Financial Statement Quarter 2/2024 (09/08/2024)

>   TB8: Reviewed Semi-annual Financial Statements 2024 (09/08/2024)

>   ACM: Financial Statement Quarter 2/2024 (09/08/2024)

>   DGT: Financial Statement Quarter 2/2024 (holding company) (09/08/2024)

>   KTC: Reviewed semi-annual financial statement 2024 (holding company) (09/08/2024)

>   MH3: Reviewed Semi-annual Financial Statements 2024 (09/08/2024)